Myo-inositol may prevent gestational diabetes in PCOS women.

  title={Myo-inositol may prevent gestational diabetes in PCOS women.},
  author={Rosario D'Anna and Victor Di Benedetto and Pietro Rizzo and Emanuela Raffone and Maria Lieta Interdonato and Francesco Corrado and Antonino di Benedetto},
  journal={Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology},
  volume={28 6},
To evaluate retrospectively the prevalence of gestational diabetes (GD) in pregnancies obtained with myo-inositol administration in women with polycystic ovary syndrome. A total of 98 pregnancies in PCOS women obtained in a 3-year period, either with myo-inositol (n. 54), or with metformin (n. 44) were considered. While myo-inositol was assumed through the whole pregnancy, the group of women treated with metformin stopped the drug assumption after pregnancy diagnosis, and was considered as a… CONTINUE READING